Health

Merck Nears $10 Billion Deal for Drugmaker Verona, FT Says

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Site feedback:

Take our Survey

By Amber Tong

July 9, 2025 at 1:16 AM EDT

Updated on

July 9, 2025 at 4:26 AM EDT

Merck & Co. is closing in on an approximately $10 billion deal to acquire respiratory drugmaker Verona Pharma, the Financial Times reported.

Merck would pay $107 per American depository share for the biotech company — a 23% premium to Tuesday’s closing price — the newspaper reported, citing unidentified people familiar with the matter.